Rafael Holdings creates value for its stockholders through investments in a portfolio of commercial real estate and in research-driven oncology therapeutics companies – all backed by a strong and liquid balance sheet.

At Rafael Pharmaceuticals, Inc. we are a pioneering, clinical-stage, metabolic oncology therapeutics company, focused on transforming the lives of patients with hard to treat cancers. Our primary objective is to produce highly selective and effective anti-cancer agents with minimal toxic effects on normal cells and tissues.


Press Release
News Coverage